Reckitt Benckiser Group PLC
LSE:RKT
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4 014.2357
5 872
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Reckitt Benckiser Group PLC
Reckitt Benckiser Group PLC
Net Issuance of Common Stock
Reckitt Benckiser Group PLC
Net Issuance of Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Reckitt Benckiser Group PLC
LSE:RKT
|
Net Issuance of Common Stock
-£161m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
McBride PLC
LSE:MCB
|
Net Issuance of Common Stock
-£2.8m
|
CAGR 3-Years
32%
|
CAGR 5-Years
20%
|
CAGR 10-Years
11%
|
|
|
Accrol Group Holdings PLC
LSE:ACRL
|
Net Issuance of Common Stock
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Reckitt Benckiser Group PLC
Glance View
Reckitt Benckiser Group PLC, a multinational consumer goods company based in the UK, has carved a prominent niche in the health, hygiene, and home categories. With a portfolio of trusted brands such as Dettol, Lysol, Nurofen, and Air Wick, Reckitt is committed to enhancing everyday life through innovative products that promote well-being and cleanliness. Founded in 1823, the company has evolved significantly, leveraging its strong market presence and expanding its product reach to meet the changing needs of consumers worldwide. As a strategic player in the fast-moving consumer goods sector, Reckitt's operational model focuses on efficiency and sustainability, making it an attractive candidate for investors looking for stable growth in a resilient sector. Continually adapting to global trends, Reckitt has embraced digital transformation and sustainability initiatives to drive long-term value. The company has prioritized investments in research and development, leading to new product innovations that cater to shifting consumer preferences, particularly in the wake of heightened health awareness during the COVID-19 pandemic. By focusing on operational excellence, including cost management and supply chain optimization, Reckitt has positioned itself for resilience and profitability. For investors, Reckitt Benckiser represents a compelling opportunity with its strong brand portfolio, commitment to sustainability, and a strategic approach to navigating the evolving consumer landscape, underscoring its potential for both dividend stability and capital appreciation.
See Also
What is Reckitt Benckiser Group PLC's Net Issuance of Common Stock?
Net Issuance of Common Stock
-161m
GBP
Based on the financial report for Dec 31, 2023, Reckitt Benckiser Group PLC's Net Issuance of Common Stock amounts to -161m GBP.
You don't have any saved screeners yet
